Our Strategic Collaboration

LEXEO was founded based on 25 years of well-established gene therapy research legacy at Weill Cornell Medicine’s Department of Genetic Medicine by a team of pioneering scientists, clinicians, and business leaders with deep expertise in gene therapy. We maintain collaborations with Weill Cornell and other leading institutions to advance disease-modifying gene therapies for genetic conditions.

Our Investors